Environmental

CVRx appears less exposed to direct environmental externalities than industrial peers because its cardiac-device model is not energy- or emissions-intensive, limiting near-term regulatory pressure.

The company’s R&D-to-revenue intensity of about 20% suggests a comparatively innovation-led footprint, but peer-relative environmental disclosure remains limited versus larger medtech peers.

No provided evidence indicates material waste, water, or climate-transition liabilities, yet the absence of detailed filings-based metrics prevents a stronger environmental score versus better-disclosed peers.

Overall environmental positioning is middling because low operational footprint helps, but peer-leading environmental transparency and quantified targets are not evident from the available data.

Social

CVRx’s high R&D intensity supports patient-benefit innovation, but peer-relative social strength is constrained by the absence of provided data on clinical outcomes, access, or product safety disclosures.

Stock-based compensation at roughly 20% of revenue can aid talent retention in a specialized device business, though it may also signal heavier dilution pressure than better-aligned peers.

As a medical-device company, product quality and post-market surveillance are material social factors, yet no filings-based evidence here shows superior performance versus peers.

The social profile is therefore moderate because the business model is inherently patient-focused, but the available evidence does not establish a clear advantage over comparable medtech companies.

Governance

Debt-to-equity of about 3.0 indicates meaningful leverage relative to many medtech peers, which can constrain governance flexibility and heighten oversight demands.

Net debt to EBITDA is low at roughly 0.1, partially offsetting balance-sheet risk, but peer-relative governance strength still depends on broader capital-allocation discipline.

Stock-based compensation near 20% of revenue suggests compensation intensity that may dilute shareholders more than better-disciplined peers if not tightly governed.

Without filings-based board, audit, or controversy evidence, governance appears average rather than advantaged, with leverage and compensation structure the main relative concerns.

Overall Score

CVRx’s ESG positioning is broadly average versus peers, with a low direct environmental footprint and patient-focused business model offset by limited disclosure and governance intensity.

Score Driver: Limited Peer-Relative ESG Disclosure And Only Moderate Governance Structure Strength